- News & Events
- Contact Us
|View printer-friendly version|
|Amgen Announces Award for Science Teaching Excellence|
|Call for Nominations|
Nominations Due February 29, 2004
Louisville, KY (January 5, 2004) – Amgen Inc. (NASDAQ:AMGN), the world's largest biotechnology company, today announced it has begun accepting nominations for the 2004 Amgen Award for Science Teaching Excellence, the company's recognition program for science education. Two K-12 educators who teach in either public or private schools in the Jefferson County school district will each receive an unrestricted $10,000 award from Amgen, and will be honored at an award dinner in May.
For six years, Amgen has offered its teaching award in Jefferson County. In recent years, the company has modified the award to focus solely on excellence in science teaching. Amgen also conducts similar programs in California; Colorado; Boston and Cambridge, Massachusetts; Puerto Rico; Rhode Island; and Seattle, Washington.
Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level taught by the science teacher; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award. The letter should describe the teacher's attributes in the areas of creativity, teaching effectiveness, best practice development, and instructional and motivational ability.
Letters should be sent to: Amgen Award for Science Teaching Excellence, Attn: Sandra Klein, Amgen Louisville Distribution Center, 12000 Plantside Drive, Louisville, KY 40299. Nominations can also be submitted electronically, at www.Amgen.com/ScienceTeacherAward/. Nominations for the award will be accepted immediately, through February 29, 2004.
Amgen Announces Award for Science Teaching Excellence
Amgen is a global biotechnology company that discovers, develops, manufactures and markets cost-effective human therapeutics based on advances in cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
EDITORS NOTE: An electronic version of this news release may be accessed via our Web site at www.amgen.com. Journalists and media representatives may sign up to receive all news releases electronically at the time of announcement by filling out a short form in the Media section of the Web site.